These findings indicate that APS can reverse multidrug resistance by inhibiting the P-GP function and expression, thereby enhancing the sensitivity of resistant tumour cells to chemotherapy and enabling effective tumour inhibition at lower doxorubicin concentrations. The gene discussed is PGP; the disease is neoplasm.